Stericycle (NASDAQ:SRCL) PT Lowered to $55.00

Stericycle (NASDAQ:SRCL - Get Free Report) had its price objective dropped by investment analysts at Robert W. Baird from $62.00 to $55.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has a "neutral" rating on the business services provider's stock. Robert W. Baird's price objective points to a potential upside of 18.76% from the stock's previous close.

SRCL has been the topic of a number of other reports. Royal Bank of Canada reissued an "outperform" rating and set a $69.00 price objective on shares of Stericycle in a report on Thursday, March 7th. Wells Fargo & Company raised their price objective on Stericycle from $40.00 to $48.00 and gave the company an "underweight" rating in a report on Friday, March 1st. Truist Financial raised their price objective on Stericycle from $50.00 to $57.00 and gave the company a "hold" rating in a report on Thursday, February 29th. StockNews.com lowered Stericycle from a "buy" rating to a "hold" rating in a research report on Tuesday, April 2nd. Finally, Stifel Nicolaus raised their price target on Stericycle from $70.00 to $75.00 and gave the stock a "buy" rating in a research report on Thursday, February 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $60.80.

Stericycle Price Performance

Shares of NASDAQ:SRCL traded down $0.20 on Friday, hitting $46.31. The company's stock had a trading volume of 802,019 shares, compared to its average volume of 467,025. The company has a 50-day simple moving average of $51.35 and a 200 day simple moving average of $48.17. Stericycle has a 1 year low of $37.78 and a 1 year high of $57.06. The company has a market capitalization of $4.30 billion, a PE ratio of -192.95, a PEG ratio of 2.68 and a beta of 1.09. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.94 and a quick ratio of 0.94.

Stericycle (NASDAQ:SRCL - Get Free Report) last released its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analysts' expectations of $676.42 million. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. The company's revenue was down 2.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.49 EPS. Sell-side analysts forecast that Stericycle will post 2.32 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of SRCL. Principal Securities Inc. bought a new stake in shares of Stericycle in the fourth quarter worth $41,000. GAMMA Investing LLC boosted its stake in shares of Stericycle by 170.9% in the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider's stock worth $43,000 after acquiring an additional 516 shares during the period. TFO Wealth Partners LLC boosted its stake in shares of Stericycle by 22,325.0% in the fourth quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider's stock worth $44,000 after acquiring an additional 893 shares during the period. Exchange Traded Concepts LLC lifted its position in shares of Stericycle by 87.5% in the third quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider's stock worth $45,000 after buying an additional 467 shares in the last quarter. Finally, Ramirez Asset Management Inc. purchased a new stake in shares of Stericycle in the third quarter worth about $45,000. Hedge funds and other institutional investors own 98.82% of the company's stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.